Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

2008; Elsevier BV; Volume: 19; Issue: 7 Linguagem: Inglês

10.1093/annonc/mdn058

ISSN

1569-8041

Autores

Markus Borner, Dieter Koeberle, Roger von Moos, Piercarlo Saletti, Daniel Rauch, Viviane Hess, Andreas Trojan, Daniel Helbling, Bernhard C. Pestalozzi, Clemens B. Caspar, Thomas Ruhstaller, A. Roth, Андреас Каппелер, Damien Dietrich, Doris Lanz, Walter Mingrone,

Tópico(s)

Hepatocellular Carcinoma Treatment and Prognosis

Referência(s)